Provided by Tiger Fintech (Singapore) Pte. Ltd.

BridgeBio Pharma, Inc.

46.97
-0.7250-1.52%
Pre-market: 47.520.5550+1.18%07:16 EDT
Volume:2.42M
Turnover:114.03M
Market Cap:8.92B
PE:-13.28
High:48.42
Open:48.19
Low:46.63
Close:47.69
Loading ...
Aug 21, 2024

Major Issues Report

Form 8-K - Current report
Aug 20, 2024

Beneficial Ownership Change

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Aug 20, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 19, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 01, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 01, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Aug 01, 2024

Major Issues Report

Form 8-K - Current report
Jul 23, 2024

Major Issues Report

Form 8-K - Current report
Jun 24, 2024

Major Issues Report

Form 8-K - Current report
Jun 06, 2024

Major Issues Report

Form 8-K - Current report
Jun 04, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 03, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 02, 2024

Major Issues Report

Form 8-K - Current report
Mar 06, 2024

Major Issues Report

Form 8-K - Current report
Mar 04, 2024

Major Issues Report

Form 8-K - Current report
Feb 22, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 22, 2024

Major Issues Report

Form 8-K - Current report
Feb 16, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 16, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]